DUBLIN--(BUSINESS WIRE)--The "Anatomic Pathology Market Research Report: By Product, type, technique, Application, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
This is attributed to the surging aging population and rising number of patients suffering from the chronic ailments. When segmented by end user, the anatomic pathology market is classified into diagnostic laboratories, ambulatory surgical centers, hospitals and clinics, and academic and research organizations. Among these, in 2018, diagnostic laboratories led the market with a share of 45.8%, followed by hospitals and clinics that held a 31.4% share. The reason behind this is that these laboratories are less expensive as compared to hospitals and clinics.
The Asia-Pacific (APAC) anatomic pathology market is predicted to witness the fastest growth at a 6.7% CAGR during the forecast period. The key factors responsible for such rapid progress would be the acceptance of personalized medicine, growing number of chronic ailment patients, increasing investment in diagnostic research by non-government and government organizations, and entry of established players in the region. The increasing entrance rate of international players in the market is helping in better availability of advanced and innovative anatomic pathology consumables and instruments in APAC.
For instance, in January 2019, Nichirei Bioscience (one of the leading suppliers of diagnostic and biological products in Japan) collaborated with Biocartis Group NV for the product registration and exclusive distribution of molecular diagnostic (MDx) oncology tests, developed by Biocartis, in Japan, which work on the sample-to-result Idylla platform, which is fully automated, Under this, Nichirei Bioscience agreed to get the regulatory approval of the Japanese Ministry of Health, Labour, and Welfare for Idylla MDx oncology tests. After the registration, Nichirei Bioscience aims to provide Biocartis' Idylla platform to 2,000 pathology laboratories within its commercial network in Japan.
The key players operating in the anatomic pathology market are gearing up to introduce innovative solutions to improve their market presence. For instance, in February 2019, Quest Diagnostics Inc., a U.S.-based diagnostic information services provider, purchased the clinical laboratory services unit of Boyce & Bynum Pathology Laboratories (BBPL), a leading supplier of diagnostic and clinical laboratory services in the Midwest. The acquisition is aimed at offering a larger portfolio of anatomic pathology and innovative clinical laboratory services to providers and patients throughout the region.
Key Topics Covered:
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Test Type
1.3.3 Market Segmentation by Technique
1.3.4 Market Segmentation by Application
1.3.5 Market Segmentation by End User
1.3.6 Market Segmentation by Region
1.3.7 Analysis Period
1.3.8 Market Data Reporting Unit
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
126.96.36.199 By region
188.8.131.52 By industry participant
184.108.40.206 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
220.127.116.11.1.2 Stains and dyes
18.104.22.168.1 Tissue processors
22.214.171.124.2 Slide stainers
4.1.2 By Test Type
126.96.36.199 Surgical pathology
4.1.3 By Technique
188.8.131.52 Special staining
184.108.40.206 Electron microscopy
220.127.116.11 Genetic testing
4.1.4 By Application
18.104.22.168 Disease diagnosis
22.214.171.124 Drug discovery
4.1.5 By End User
126.96.36.199 Diagnostic laboratories
188.8.131.52 Hospitals and clinics
184.108.40.206 Ambulatory surgical centers
220.127.116.11 Academic and research organizations
4.2 Market Dynamics
4.3 Porter's Five Forces Analysis
4.4 Technological Advancements
4.5 Regulatory Framework
4.5.1 North America
4.6 Pricing Analysis
Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Consumables Market by Type
18.104.22.168 Reagents market by type
5.1.2 Instruments Market by Type
5.2 By Test Type
5.3 By Technique
5.4 By Application
5.4.1 Disease Diagnosis Market by Type
5.5 By End User
5.6 By Region
Chapter 6. North America Market Size and Forecast
Chapter 7. Europe Market Size and Forecast
Chapter 8. APAC Market Size and Forecast
Chapter 9. LATAM Market Size and Forecast
Chapter 10. MEA Market Size and Forecast
Chapter 11. Competitive Landscape
11.1 Company Benchmarking Based on Offerings
11.2 Technique Benchmarking of Key Players
11.3 Global Strategic Developments of Key Players
11.3.1 Acquisitions and Collaborations
11.3.2 New Product Launches and Patent Approvals
Chapter 12. Company Profiles
12.1 Key Players
12.1.1 Thermo Fisher Scientific Inc.
22.214.171.124 Business overview
126.96.36.199 Product and service offerings
188.8.131.52 Key financial summary
12.1.2 Danaher Corporation
12.1.3 F. Hoffmann-La Roche Ltd.
12.1.4 Quest Diagnostics Incorporated
12.1.5 Bio-Rad Laboratories Inc.
12.1.6 Agilent Technologies Inc.
12.1.7 Neogenomics Laboratories Inc.
12.1.8 Abbott Laboratories
12.1.9 Sakura Finetek USA Inc.
12.1.10 OriGene Technologies Inc.
12.1.11 Biocare Medical LLC
12.1.12 Sonic Healthcare Limited
12.1.13 DTM Print GmBH
12.2 Other Players
12.2.1 Caris Life Sciences Inc.
12.2.2 Sunquest Information Systems Inc.
12.2.3 Inform Diagnostics Inc.
12.2.4 Interpath Laboratory Inc.
For more information about this report visit https://www.researchandmarkets.com/r/e2zwab